Published in Biotech Law Weekly, July 28th, 2006
This license agreement covers specific patents, patent applications and know how related to the encapsulation and preservation of therapeutics for the coating on its PyraDerm transdermal drug delivery platform. The company also signed a 1 year sponsored research agreement to further develop and optimize the licensed technologies.
Nevenka Golubovic-Liakopoulos, Apogee's director of Medical Products, said,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.